Your browser doesn't support javascript.
loading
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.
Cejas, Paloma; Xie, Yingtian; Font-Tello, Alba; Lim, Klothilda; Syamala, Sudeepa; Qiu, Xintao; Tewari, Alok K; Shah, Neel; Nguyen, Holly M; Patel, Radhika A; Brown, Lisha; Coleman, Ilsa; Hackeng, Wenzel M; Brosens, Lodewijk; Dreijerink, Koen M A; Ellis, Leigh; Alaiwi, Sarah Abou; Seo, Ji-Heui; Baca, Sylvan; Beltran, Himisha; Khani, Francesca; Pomerantz, Mark; Dall'Agnese, Alessandra; Crowdis, Jett; Van Allen, Eliezer M; Bellmunt, Joaquim; Morrisey, Colm; Nelson, Peter S; DeCaprio, James; Farago, Anna; Dyson, Nicholas; Drapkin, Benjamin; Liu, X Shirley; Freedman, Matthew; Haffner, Michael C; Corey, Eva; Brown, Myles; Long, Henry W.
Afiliação
  • Cejas P; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA. paloma_cejas@dfci.harvard.edu.
  • Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. paloma_cejas@dfci.harvard.edu.
  • Font-Tello A; Translational Oncology Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ) and CIBERONC, La Paz University Hospital, Madrid, Spain. paloma_cejas@dfci.harvard.edu.
  • Lim K; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Syamala S; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Qiu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Tewari AK; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Shah N; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Nguyen HM; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Patel RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Brown L; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Coleman I; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Hackeng WM; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Brosens L; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Dreijerink KMA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ellis L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Alaiwi SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Seo JH; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Baca S; Department of Urology, University of Washington, Seattle, WA, USA.
  • Beltran H; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Khani F; Department of Urology, University of Washington, Seattle, WA, USA.
  • Pomerantz M; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Dall'Agnese A; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Crowdis J; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Van Allen EM; Department of Endocrinology, Amsterdam UMC, Amsterdam, The Netherlands.
  • Bellmunt J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Morrisey C; Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Nelson PS; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • DeCaprio J; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Farago A; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Dyson N; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Drapkin B; Weill Cornell Medical Center, Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, New York, NY, USA.
  • Liu XS; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Freedman M; Whitehead Institute for Biomedical Research, 455 Main Street, Cambridge, MA, 02142, USA.
  • Haffner MC; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Corey E; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
  • Long HW; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nat Commun ; 12(1): 5775, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34599169
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fatores de Transcrição / Carcinoma Neuroendócrino Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fatores de Transcrição / Carcinoma Neuroendócrino Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos